TIGIT and nonpapillary renal cell carcinoma: In addition, among the inhibitory receptors and other molecules involved in negative signaling, we did not observe differences in the expression of NKG2A and TIGIT in CD3-CD56bright and CD3-CD56dim NK cells from ccRCC patients compared to HD (not shown).